RxDoctor Payments Data

Robert Feldman, MD

Obstetrics · South Miami, FLNPI 1053394205

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $6,750 of the $10,395 with a category attached, or 64.9%. 27 manufacturers reported payments, led by Duchesnay USA Incorporated at 53.3% of the total. Reporting peaked in 2019 at $7,469 and has fallen 98.9% since, to $82 in 2025. Among obstetrics clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,395in general payments, 2019–2025

Across 131 payments — averaging $79.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Duchesnay USA Incorporated$6K
  • Pfizer$2K
  • Sanofi Pasteur Inc.$1K
  • AbbVie$710
  • Astellas Pharma US Inc$220
  • Mayne Pharma Commercial LLC$124
  • plus $992 from 21 others
$562,814in research payments, 2019–2025

Across 15 payments — averaging $37,521 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Janssen Research & Development, LLC$326K
  • Biogen$161K
  • Sanofi Pasteur Inc.$56K
  • Pfizer$17K
  • BD$3K

What the payments were for

  • Consulting fees$1,02410%
  • Speaking & faculty fees$6,75065%
  • Food & beverage$2,41223%
  • Education$2092%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,395 in reported general payments places this provider in the 90th percentile of 78 obstetrics providers in Florida.

See all obstetrics providers in Florida

Medicare billing

Part B allowed, 2024
$32,868
Medicare patients
154
Services billed
478

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol52$4,081
YuvafemEstradiol23$3,487
Estradiol (Twice Weekly)Estradiol20$2,385
ProgesteroneProgesterone, Micronized59$1,539
ValacyclovirValacyclovir Hcl12$342
Oxybutynin Chloride ErOxybutynin Chloride18$169
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst14$112
Alprazolam11$57

Paid to pharmacies, not to this prescriber.

Other obstetrics in South Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →